Efficacy and safety of dihydroartemisinin–piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial

Efficacy and safety of dihydroartemisinin–piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial

Abstract Background HIV-infected individuals on antiretroviral therapy (ART) require treatment with artemisinin-based combination therapy (ACT) when infected with malaria. Dihydroartemisinin–piperaquine (DPQ) is recommended for treatment of Plasmodium falciparum malaria, but its efficacy and safety...

Full description

Bibliographic Details
Main Authors: Esperança Sevene, Clifford G. Banda, Mavuto Mukaka, Sonia Maculuve, Salésio Macuacua, Anifa Vala, Mireia Piqueras, Linda Kalilani-Phiri, Jane Mallewa, Dianne J. Terlouw, Saye H. Khoo, David G. Lalloo, Victor Mwapasa
Format: Article
Language:English
Published: BMC 2019-08-01
Series:Malaria Journal
Subjects:
Human immunodeficiency virus
Antiretroviral drugs
Dihydroartemisinin–piperaquine
Malaria
Drug–drug interactions
Online Access:http://link.springer.com/article/10.1186/s12936-019-2909-5

Internet

http://link.springer.com/article/10.1186/s12936-019-2909-5

Similar Items